No Data
No Data
Weekly IPO | Minimally Invasive Robots is being subscribed, and Wanda Commercial Management returns to the Hong Kong Stock Exchange
Wang Jianlin is back! Wanda Commercial Management submitted the form 5 years later; Eagle Eye Technology, the “first medical AI stock”, and Tianrunyun, China's largest enterprise cloud service provider, passed the hearing; Weitai Healthcare successfully listed the “A+H” stock.
Interview with Zhang Dalei, founder of Eagle Eye Technology: Medical AI will run a long distance for 50 years
What exactly was the reason for Zhang Dalei, who worked for Microsoft, PPTV, Sina, etc., and was originally a programmer, to give up his well-paid executive position and choose what seemed like a thorny sheep gut at the time?
IPO | Eagle Eye Technology updates prospectus after Hong Kong Stock Exchange hearing
On October 22, Capital Bank learned that Beijing Eagle Eye Technology Development updated its prospectus after the hearing on the Hong Kong Stock Exchange and that it will be listed in Hong Kong soon. UBS and CITIC Securities are their joint sponsors. According to hearing data, Eagle Eye Technology is an artificial intelligence medical device company that mainly provides early detection, auxiliary diagnosis and health risk assessment solutions for artificial intelligence retinal image recognition. There are three versions of AirDoc-Aifundus, a self-developed core product in the Eagle Eye Technology product portfolio. AirDoc-AiFundus (1.0) is an artificial intelligence doctor
AI Medical IPO Eve: players impact 100 million yuan in annual revenue, track wars are commercialized
AI Healthcare listing trend: more than 100 million years of revenue has become reality, valuation of $1 billion has become the norm.
The first AI medical stock is coming! Eagle Eye Technology was the first to be heard
According to the data, by providing revenue from artificial intelligence software solutions, Eagle Eye Technology's revenue for the first three months of 2021 reached 1,555 million yuan, an increase of 981.6% over the previous year. The increase was strong, accounting for 88.2% of total revenue, and 2,022 million yuan of hardware equipment sales revenue, accounting for 9.1% of total revenue.
IPO interpretation | Eagle Eye Technology took the lead in the hearing to decipher the first medical AI stock
The AI medical imaging market has a market capitalization potential of 100 billion dollars, and the development prospects are promising. Eagle Eye Technology uses the AI retina to enter this circuit and has a clear first-mover advantage.
No Data
No Data